
Versalis Buys Italian Compounder Tecnofilm
Following regulatory approval of the deal, Italian chemical company Versalis has completed the acquisition of compounder Tecnofilm.
Following regulatory approval of the deal, Italian chemical company Versalis has completed the acquisition of compounder Tecnofilm.
As part of its strategy to expand the company's application portfolio, Germany-based OQ Chemicals has mechanically completed the expansion of its US plant in Bay City, Texas, for the production of high-purity propionaldehyde.
Fujifilm announced an additional investment of $1.2 billion in its large-scale cell culture contract development and manufacturing organization (CDMO) business to further expand the planned Fujifilm Diosynth Biotechnologies facility in Holly Springs, North Carolina, bringing the total investment in the facility to over $3.2 billion. Plans for the new site were unveiled in September last year.
Air Liquide is to expand its capacities in biomethane, also known as renewable natural gas (RNG) in the US, with the construction of two new production units. These units, located in Center Township, Pennsylvania, and Holland Township, Michigan, will treat waste sourced from dairy farms.
Australia-headquartered lithium producer Vulcan Energy Resources has started production of lithium chloride (LiCl) at its lithium extraction optimization plant (LEOP) in Landau, Germany. The company started the plant up in November last year.
Novoloop, a plastic circular economy technology company, recently announced the successful startup of its pilot plant in India in collaboration with Aether Industries, a publicly listed specialty chemicals manufacturer.
US-based Vertex Pharmaceuticals has agreed to pay approximately $4.9 billion in cash to acquire Alpine Immune Sciences, a compatriot biotechnology company focused on discovering and developing innovative, protein-based immunotherapies.
In its Chemical Trends Report for March, CEFIC, the European Chemical Industry Council, states that Europe has been more impacted by the energy crisis than other regions and structural issues need to be addressed.
Specialty chemicals company Orion, a producer of carbon black, broke ground on a battery materials plant in Texas, US. According to Orion, the facility will be the only one in the US producing acetylene-based conductive additives for lithium-ion batteries and other applications for the growing electrification.
Roquette, a French multinational supplier of pharmaceutical and nutraceutical excipients, announced an investment by its venture capital arm Roquette Ventures in Danish start-up Biograil.
DKSH has announced the signing of an agreement to acquire Malaysia's Elite Organic Sdn. Bhd. This acquisition allows DKSH Performance Materials to enhance its capabilities in the promising pharmaceutical, food, and nutraceutical markets across the Asia Pacific region.
Finnish refiner Neste and South Korean chemical company Lotte Chemical agreed on a strategic collaboration to replace fossil resources with renewable raw materials in the manufacturing of chemicals and plastics. This, the partners said, will enable products and applications with a lower carbon footprint compared to those produced from fossil resources.
TotalEnergies and China Petroleum and Chemical Corporation (Sinopec) have agreed to develop a production unit for sustainable aviation fuel (SAF) at a Sinopec's refinery in China.
German distribution giant Brenntag announced the acquisition of Lawrence Industries, an independent specialties distributor in the UK. The transaction, Brenntag said, further strengthens the company’s position within Material Science and across the coatings, adhesives, sealants and elastomers (CASE), construction, polymer and rubber industries. Financial details of the deal were not disclosed.
Azelis continues its acquisition spree, this time adding Indonesian distributor PT Marga Dwi Kencana (MDK) to its portfolio. Financial details of the deal were not disclosed.
Danish drugmaker Genmab has agreed to buy privately-owned US biotechnology company ProfoundBio for $1.8 billion. ProfoundBio develops novel ADCs and ADC technologies for the treatment of certain cancers, including ovarian cancer and other FRα-expressing solid tumors.
Clariant, a specialty chemical company, announced it has completed the acquisition of Lucas Meyer Cosmetics, a provider of high-value ingredients for the cosmetics and personal care industry, from IFF for an Enterprise Value (EV) of $810 million (€746 million). The purchase price will be subject to customary net debt and working capital adjustments.
Upperton Pharma Solutions was joined by Sarah Gilbert, Professor and co-creator of the Oxford/AstraZeneca COVID-19 vaccine for the official opening of its new development and GMP manufacturing facility in Nottingham, UK.
Swiss construction chemicals major Sika has acquired Kwik Bond Polymers (KBP), a US-based manufacturer of polymer systems for the refurbishment of concrete infrastructure. Financial details of the transaction were not disclosed.
Swiss specialty chemicals producer Archroma announced plans to expand its US operations in Martin, South Carolina.
Lonza has appointed Wolfgang Wienand as its new CEO. He will join the company during the summer of 2024 and succeed Albert M. Baehny, who took on the additional responsibility of interim CEO in October 2023 while the search for a permanent CEO took place.
Ineos has completed the acquisition of Naphtachimie, Gexaro and Appryl, which were 50:50 Joint Ventures between Ineos and TotalEnergies at Lavera in Southern France.
Aragen, a CRDMO, has launched the first phase of its biologics manufacturing facility in Bangalore, India. The $30 million project, executed by its subsidiary Aragen Biologics Pvt Ltd, has completed its first small-scale manufacturing project for a US-based organization, producing a novel anticancer monoclonal antibody.
Syensqo has opened its application development labs (ADL) in Bollate, Italy. The project includes an expansion of 1,300 m2 in a new building and represents a €10 million investment over the past three years and underlines the Bollate research center’s pivotal role in developing new applications for high-tech industries, the company said.
US specialty chemicals and materials company Chemours has appointed Denise Dignam as the company’s permanent CEO and president, as well as a member of the board of directors, effective immediately.
US chemical group Celanese and Germany’s Secarna Pharmaceuticals, an antisense drug discovery and development company, entered a research collaboration for the development of long-acting implants that deliver antisense oligonucleotides (ASOs).
Sandoz, a generic and biosimilar medicines manufacturer, recently opened a new production facility in Kundl, Austria, to serve more patients with affordable life-saving drugs produced entirely in Europe.
Dow announced its intent to build a world-scale carbonate solvents production facility for lithium-ion battery production on the US Gulf Coast. The plant will serve customers in the lithium-ion battery sector, in which carbonate solvents are used as a component in electrolytes.
Novo Nordisk is to acquire Cardior Pharmaceuticals for up to €1.025 billion Euros, including an upfront payment and additional payments if certain development and commercial milestones are achieved.
UK’s Johnson Matthey (JM) has signed a definitive agreement to sell 100% of its Medical Device Components (MDC) business to Montagu Private Equity for $700 million (£550 million).
In a move to triple its production of glass and polymer syringes for the US market by 2030, Germany’s Schott Pharma announced plans to build its first US facility to manufacture prefillable polymer syringes that meet the need for deep-cold storage and transportation of mRNA medications.
AstraZeneca has agreed to acquire Fusion Pharmaceuticals, a clinical-stage biopharmaceutical company developing next-generation radioconjugates (RCs).
Greentech firm Afyren Neoxy, a subsidiary of Afyren, received a €3.4 million payment this week for achieving key milestones with its bio-based low-carbon products.
Evonik Vland Biotech, a new joint venture between Evonik China and Shandong Vland Biotech, began operations on January 1, 2024. The venture aims to expand the market presence of their livestock probiotics in Greater China and develop new products. The official opening took place in Qingdao on March 14.
Interview with Edgardo Hernandez, President Manufacturing, Lilly